Loading...
Australian Clinical Labs Limited
ACL.AX•ASX
Healthcare
Medical - Diagnostics & Research
A$2.72
A$-0.04(-1.45%)
Australian Clinical Labs Limited (ACL.AX) Financial Performance & Income Statement Overview
Review Australian Clinical Labs Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.34%
↓ 0.34%
Operating Income Growth
9.75%
↑ 9.75%
Net Income Growth
-33.33%
↓ 33.33%
Operating Cash Flow Growth
11.07%
↑ 11.07%
Operating Margin
36.49%
↑ 36.49%
Gross Margin
36.49%
↑ 36.49%
Net Profit Margin
4.21%
↑ 4.21%
ROE
17.72%
↑ 17.72%
ROIC
70.46%
↑ 70.46%
Australian Clinical Labs Limited (ACL.AX) Income Statement & Financial Overview
Review Australian Clinical Labs Limited's (ACL.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $359.10M | $333.72M | $336.76M | $168.38M |
| Cost of Revenue | $223.01M | $273.30M | $266.02M | $107.63M |
| Gross Profit | $136.09M | $60.42M | $70.74M | $60.75M |
| Gross Profit Ratio | $0.38 | $0.18 | $0.21 | $0.36 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$5.35M | $44.56M | $48.57M | $0.00 |
| Operating Expenses | $0.00 | $41.60M | $48.57M | $49.23M |
| Total Costs & Expenses | $223.01M | $314.89M | $314.59M | $156.86M |
| Interest Income | $662000.00 | $170000.00 | $60000.00 | $3.74M |
| Interest Expense | $17.47M | $8.30M | $7.54M | $0.00 |
| Depreciation & Amortization | $6.70M | $63.70M | $61.90M | $3.42M |
| EBITDA | $45.83M | $79.81M | $84.99M | $18.05M |
| EBITDA Ratio | $0.13 | $0.25 | $0.25 | $0.11 |
| Operating Income | $136.09M | $18.83M | $22.17M | $14.62M |
| Operating Income Ratio | $0.38 | $0.06 | $0.07 | $0.09 |
| Other Income/Expenses (Net) | -$107.53M | -$11.02M | -$6.62M | -$53.57M |
| Income Before Tax | $28.56M | $7.81M | $15.55M | $7.78M |
| Income Before Tax Ratio | $0.08 | $0.02 | $0.05 | $0.05 |
| Income Tax Expense | $9.39M | $2.73M | $4.99M | $2.50M |
| Net Income | $18.98M | $4.95M | $10.48M | $5.24M |
| Net Income Ratio | $0.05 | $0.01 | $0.03 | $0.03 |
| EPS | $0.10 | $0.02 | $0.05 | $0.03 |
| Diluted EPS | $0.10 | $0.02 | $0.05 | $0.03 |
| Weighted Avg Shares Outstanding | $198.65M | $200.50M | $200.50M | $201.39M |
| Weighted Avg Shares Outstanding (Diluted) | $198.99M | $201.33M | $201.37M | $201.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan